Your prediction
Pros and Cons of Braskem Pfd ADR in the next few years
Pros
?
S********** s********
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Braskem Pfd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Braskem Pfd ADR | 1.680% | -1.653% | -1.653% | -33.889% | -33.889% | -71.152% | -66.944% |
| Braskem Pfd A | 0.900% | -13.281% | -2.632% | -41.885% | -41.885% | -72.388% | -68.466% |
| Ingevity Corp | -1.260% | 0.697% | 13.047% | 31.634% | 31.634% | - | - |
| PTT Global Chemical -fgn- | 0.940% | -1.852% | 6.000% | -18.462% | -18.462% | -58.268% | -66.242% |
Comments
Braskem S.A. (NYSE: BAK) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.
Show more
Ratings data for BAK provided by MarketBeat
Braskem S.A. (NYSE: BAK) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Show more
Ratings data for BAK provided by MarketBeat
Braskem S.A. (NYSE: BAK) was downgraded by analysts at UBS Group AG from a "neutral" rating to a "sell" rating.
Show more
Ratings data for BAK provided by MarketBeat